New Drug Maybe in Sight to Treat Diabetes-Related Blindness

Australian scientists have developed a novel drug which could potentially be used to effectively treat patients with diabetic retinopathy; the main …

Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List

Teva Pharmaceutical Industries announced this week it is voluntarily recalling some of its blood pressure drugs in the U.S. due to an impurity in …

FDA Issues Voluntary Recall of Blood Pressure Medication Due to Cancer Concerns

A voluntary recall of a blood pressure medication due to impurities, which may lead to a cancer risk, was recently issued by Sandoz Inc. The company …

Security Guidelines for Air Travel With Diabetes

The holidays are coming, and that means it’s travel time for many to spend time with friends and family. If you have diabetes, you should be …

Lilly’s Trulicity® Shows Reduction of Cardiovascular Events for Broad Range of People with Type 2 Diabetes

Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of …

Endocrine Society Urges More Transparency to Combat Soaring Insulin Costs

Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to …

Xeris Pharma Announces FDA to Review NDA for Its Ready-to-Use Glucagon Rescue Pen

Xeris Pharmaceuticals, Inc. announced today that its new drug application (NDA) for its ready-to-use, room-temperature stable liquid glucagon rescue …

FDA Approves New Influenza Drug, Just in Time for Flu Season

Genentech announced yesterday that the U.S. Food and Drug Administration (FDA) has approved XOFLUZA™ for the treatment of the flu, in patients …

Big 3 Insulin Makers Receive Lawsuit For “Deceptive” Price Hikes

Minnesota Attorney General Lori Swanson is the latest to file a lawsuit against the nation’s three largest insulin makers, Sanofi-Aventis U.S. …

Tresiba® for Children with Type 1 diabetes Approved in Canada

Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada. …